TLR9 and inflammatory bowel disease: Recently, Boyapati et al. showed that significantly increased levels of cfmtDNA are found in active human IBD and in mouse colitis [90], suggesting cfmtDNA-TLR9 signalling as an important and targetable pathway in IBD.